insights_auto
Why is BOT up 12.50%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0090
arrow_upward
+12.50%(+0.00100) 1D
Nov 17, 2:09:49 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
22.38M
Avg. vol.
10.87M
Volume
3.62M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
22.38M
Avg. vol.
10.87M
Volume
3.62M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
marketscreener.com
·
5 hours ago
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
BigGo Finance
·
13 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
ChartMill
·
9 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
www.tokenpost.com
·
49 minutes ago
Defensive S&P 500 Sectors Outpace Nasdaq 100 by 26 Percentage Points
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com